Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

Also called NCT01946815

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 119 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01946815
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01946815. Allocation not applicable; no masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2018-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease
Acronym
FORTE
Intervention (Drug)
Atorvastatin
Lead sponsor
Keimyung University Dongsan Medical Center (class: other)
Collaborator
Seoul National University Hospital (class: other)
Collaborator
Ulsan University Hospital (class: other)
Collaborator
Inje University Ilsan Paik Hospital (class: other)

Record details

Record id
cardio:ct-nct01946815
Content hash
c06b9e2d1fc947454b674015dc652e3e5b412c39c771f747b1983c68cf9a0d7d